UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)

Annals of the rheumatic diseases, 2017-12, Vol.76 (12), p.2071-2074

2017

Volltextzugriff (PDF)

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis

Arthritis research & therapy, 2013-10, Vol.15 (5), p.R164-R164, Article R164

2013

Volltextzugriff (PDF)

Clinical diagnosis of Chikungunya infection: An essential aid in a primary care setting where serological confirmation is not available

Tropical medicine and infectious disease, 2023-04, Vol.8 (4), p.1-16

2023

Volltextzugriff (PDF)

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

The Lancet (British edition), 2018-07, Vol.392 (10143), p.222-231

2018

Volltextzugriff (PDF)

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

The Lancet (British edition), 2023-03, Vol.401 (10381), p.1011-1019

2023

Volltextzugriff (PDF)

Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

Arthritis & rheumatology (Hoboken, N.J.), 2013-03, Vol.65 (3), p.559-570

2013

Volltextzugriff (PDF)

PANLAR—Journal of Clinical Rheumatology 2020 Supplement

Journal of clinical rheumatology, 2020-10, Vol.26 (7S), p.S97-S97

Cardiel, Mario H.

2020

Volltextzugriff (PDF)

Challenges in the management of rheumatoid arthritis in developing countries

Best practice & research. Clinical rheumatology, 2008-08, Vol.22 (4), p.621-641

2008

Volltextzugriff (PDF)

Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2017-05, Vol.69 (5), p.932-942

2017

Volltextzugriff (PDF)

Human Genetic Host Factors and Its Role in the Pathogenesis of Chikungunya Virus Infection

Frontiers in medicine, 2022-02, Vol.9, p.654395-654395

2022

Volltextzugriff (PDF)

Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014-2015

Emerging microbes & infections, 2019-01, Vol.8 (1), p.1490-1500

2019

Volltextzugriff (PDF)

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study

Rheumatology and therapy., 2019-12, Vol.6 (4), p.503-520

2019

Volltextzugriff (PDF)

Rheumatoid arthritis in Latin America: pharmacotherapy and clinical challenges

Expert opinion on pharmacotherapy, 2024-10, Vol.25 (15), p.1-11

2024

Volltextzugriff (PDF)

Genome‐Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.932-943

2016

Volltextzugriff (PDF)

Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology

Journal of rheumatology. Supplement, 2011-01, Vol.86, p.3-8

2011

Volltextzugriff (PDF)

Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical Trials

Journal of clinical rheumatology, 2021-12, Vol.27 (8), p.e482-e490

2021

Volltextzugriff (PDF)

First Latin American position paper on the pharmacological treatment of rheumatoid arthritis

Rheumatology (Oxford, England), 2006-06, Vol.45 (suppl-2), p.ii7-ii22

Cardiel, Mario H

2006

Volltextzugriff (PDF)

Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America

Journal of rheumatology, 2021-10, Vol.48 (10), p.1616-1622

2021

Volltextzugriff (PDF)

Rheumatoid arthritis in Latin America. Important challenges to be solved

Clinical rheumatology, 2015-03, Vol.34 (Suppl 1), p.1-3

2015

Volltextzugriff (PDF)

A Critical Analysis of the First Latin American Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus

Journal of clinical rheumatology, 2022-01, Vol.28 (1), p.e312-e316

2022

Volltextzugriff (PDF)

Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study

Clinical and experimental rheumatology, 2020-09, Vol.38 (5), p.848

2020

Volltextzugriff (PDF)

Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study

Journal of clinical rheumatology, 2020-10, Vol.26 (7S), p.S180-S186

2020

Volltextzugriff (PDF)

Prevalence of musculoskeletal manifestations and related disabilities in a Peruvian urban population living at high altitude. COPCORD Study. Stage I

Reumatologia clinica, 2018-09, Vol.14 (5), p.278-284

2018

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(152)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(105)
Science & Technology
(105)
Rheumatology
(100)
Humans
(89)
Female
(55)
Rheumatoid Arthritis
(50)
Male
(49)
Adult
(48)
Middle Aged
(42)
Aged
(24)
Adolescent
(22)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Arthritis, Rheumatoid - Drug Therapy
(20)
Systemic Lupus Erythematosus
(20)
Antirheumatic Agents - Therapeutic Use
(19)
Treatment Outcome
(19)
Severity Of Illness Index
(17)
Latin America
(16)
Lupus
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis

Clinical diagnosis of Chikungunya infection: An essential aid in a primary care setting where serological confirmation is not available

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study

PANLAR—Journal of Clinical Rheumatology 2020 Supplement

Challenges in the management of rheumatoid arthritis in developing countries

Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis

Human Genetic Host Factors and Its Role in the Pathogenesis of Chikungunya Virus Infection

Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014-2015

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study

Rheumatoid arthritis in Latin America: pharmacotherapy and clinical challenges

Genome‐Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture

Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology

Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical Trials

First Latin American position paper on the pharmacological treatment of rheumatoid arthritis

Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America

Rheumatoid arthritis in Latin America. Important challenges to be solved

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort

A Critical Analysis of the First Latin American Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus

Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients

Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study

Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study

Prevalence of musculoskeletal manifestations and related disabilities in a Peruvian urban population living at high altitude. COPCORD Study. Stage I

Suchergebnisse filtern